{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T18:26:06Z","timestamp":1781807166656,"version":"3.54.5"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00109-026-02669-7","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T22:11:36Z","timestamp":1775513496000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrative multimodal transcriptomics identifies a cancer-associated fibroblast membrane signature for predicting prognosis and therapeutic response in pancreatic ductal adenocarcinoma"],"prefix":"10.1007","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7236-5546","authenticated-orcid":false,"given":"Leshi","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6333-4138","authenticated-orcid":false,"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1717-0378","authenticated-orcid":false,"given":"Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0932-8632","authenticated-orcid":false,"given":"Jian","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3070-8148","authenticated-orcid":false,"given":"Liang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4881-3210","authenticated-orcid":false,"given":"Shubo","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"issue":"8","key":"2669_CR1","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, Lyssiotis CA, Pasca di Magliano M, Maitra A (2023) Pancreatic cancer: advances and challenges. Cell 186(8):1729\u20131754","journal-title":"Cell"},{"key":"2669_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.149575","volume":"703","author":"AF Aquino","year":"2024","unstructured":"Aquino AF, Runa F, Shoma JF, Todd A, Wallace M, de Barros NR, Kelber JA (2024) Multidimensional screening of pancreatic cancer spheroids reveals vulnerabilities in mitotic and cell-matrix adhesion signaling that associate with metastatic progression and decreased patient survival. Biochem Biophys Res Commun 703:149575","journal-title":"Biochem Biophys Res Commun"},{"key":"2669_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1287459","volume":"15","author":"C Hartupee","year":"2024","unstructured":"Hartupee C, Nagalo BM, Chabu CY, Tesfay MZ, Coleman-Barnett J, West JT, Moaven O (2024) Pancreatic cancer tumor microenvironment is a major therapeutic barrier and target. Front Immunol 15:1287459","journal-title":"Front Immunol"},{"key":"2669_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.22","volume":"2","author":"J Kleeff","year":"2016","unstructured":"Kleeff J, Korc M, Apte M, La Vecchia C, Johnson CD, Biankin AV, Neale RE, Tempero M, Tuveson DA, Hruban RH et al (2016) Pancreatic cancer. Nat Rev Dis Primers 2:16022","journal-title":"Nat Rev Dis Primers"},{"key":"2669_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1555036","volume":"16","author":"R Gong","year":"2025","unstructured":"Gong R, Chen Y, Li C, Zhang H, Liu Z, Yu Q (2025) Targeting myeloid cells in pancreatic ductal adenocarcinoma: from primary tumors to liver metastasis. Front Immunol 16:1555036","journal-title":"Front Immunol"},{"issue":"8","key":"2669_CR6","doi-asserted-by":"publisher","first-page":"4962","DOI":"10.1245\/s10434-022-11579-0","volume":"29","author":"CP Zambirinis","year":"2022","unstructured":"Zambirinis CP, Midya A, Chakraborty J, Chou JF, Zheng J, McIntyre CA, Koszalka MA, Wang T, Do RK, Balachandran VP et al (2022) Recurrence after resection of pancreatic cancer: can radiomics predict patients at greatest risk of liver metastasis? Ann Surg Oncol 29(8):4962\u20134974","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"2669_CR7","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/cancers15020376","volume":"15","author":"K Dzobo","year":"2023","unstructured":"Dzobo K, Senthebane DA, Dandara C (2023) The tumor microenvironment in tumorigenesis and therapy resistance revisited. Cancers (Basel) 15(2):376","journal-title":"Cancers (Basel)"},{"issue":"2","key":"2669_CR8","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/bph.15861","volume":"181","author":"FR Borzone","year":"2024","unstructured":"Borzone FR, Giorello MB, Sanmartin MC, Yannarelli G, Martinez LM, Chasseing NA (2024) Mesenchymal stem cells and cancer-associated fibroblasts as a therapeutic strategy for breast cancer. Br J Pharmacol 181(2):238\u2013256","journal-title":"Br J Pharmacol"},{"issue":"1","key":"2669_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34395-2","volume":"13","author":"H Luo","year":"2022","unstructured":"Luo H, Xia X, Huang LB, An H, Cao M, Kim GD, Chen HN, Zhang WH, Shu Y, Kong X et al (2022) Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment. Nat Commun 13(1):6619","journal-title":"Nat Commun"},{"issue":"10","key":"2669_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05351-1","volume":"13","author":"T Zhang","year":"2022","unstructured":"Zhang T, Ren Y, Yang P, Wang J, Zhou H (2022) Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Cell Death Dis 13(10):897","journal-title":"Cell Death Dis"},{"issue":"1","key":"2669_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-023-00915-5","volume":"30","author":"Z Wu","year":"2023","unstructured":"Wu Z, Uhl B, Gires O, Reichel CA (2023) A transcriptomic pan-cancer signature for survival prognostication and prediction of immunotherapy response based on endothelial senescence. J Biomed Sci 30(1):21","journal-title":"J Biomed Sci"},{"issue":"3","key":"2669_CR12","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ccell.2018.01.011","volume":"33","author":"A Costa","year":"2018","unstructured":"Costa A, Kieffer Y, Scholer-Dahirel A, Pelon F, Bourachot B, Cardon M, Sirven P, Magagna I, Fuhrmann L, Bernard C et al (2018) Fibroblast heterogeneity and immunosuppressive environment in human breast cancer. Cancer Cell 33(3):463-479.e410","journal-title":"Cancer Cell"},{"issue":"2","key":"2669_CR13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41416-024-02904-3","volume":"132","author":"M Bruciamacchie","year":"2025","unstructured":"Bruciamacchie M, Garambois V, Vie N, Bessede T, Michaud HA, Chepeaux LA, Gros L, Bonnefoy N, Robin M, Brager D et al (2025) ATR inhibition potentiates FOLFIRINOX cytotoxic effect in models of pancreatic ductal adenocarcinoma by remodelling the tumour microenvironment. Br J Cancer 132(2):222\u2013235","journal-title":"Br J Cancer"},{"issue":"3","key":"2669_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2023.130545","volume":"1868","author":"J Wu","year":"2024","unstructured":"Wu J, Liu Y, Fu Q, Cao Z, Ma X, Li X (2024) Characterization of tumor-associated endothelial cells and the development of a prognostic model in pancreatic ductal adenocarcinoma. Biochim Biophys Acta Gen Subj 1868(3):130545","journal-title":"Biochim Biophys Acta Gen Subj"},{"issue":"1","key":"2669_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-023-01435-9","volume":"16","author":"X Zhu","year":"2023","unstructured":"Zhu X, You S, Du X, Song K, Lv T, Zhao H, Yao Q (2023) LRRC superfamily expression in stromal cells predicts the clinical prognosis and platinum resistance of ovarian cancer. BMC Med Genomics 16(1):10","journal-title":"BMC Med Genomics"},{"issue":"1","key":"2669_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/jnci\/djac178","volume":"115","author":"T Pellinen","year":"2023","unstructured":"Pellinen T, Paavolainen L, Mart\u00edn-Bernab\u00e9 A, Papatella Araujo R, Strell C, Mezheyeuski A, Backman M, La Fleur L, Br\u00fcck O, Sj\u00f6lund J et al (2023) Fibroblast subsets in non-small cell lung cancer: associations with survival, mutations, and immune features. J Natl Cancer Inst 115(1):71\u201382","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"2669_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-02862-5","volume":"23","author":"K Peng","year":"2023","unstructured":"Peng K, Zhang Y, Liu D, Chen J (2023) MMP2 is a immunotherapy related biomarker and correlated with cancer-associated fibroblasts infiltrate in melanoma. Cancer Cell Int 23(1):26","journal-title":"Cancer Cell Int"},{"issue":"2","key":"2669_CR18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.7150\/ijbs.72218","volume":"19","author":"H Wu","year":"2023","unstructured":"Wu H, Xiang Z, Huang G, He Q, Song J, Dou R, Yang C, Wang S, Xiong B (2023) BGN\/FAP\/STAT3 positive feedback loop mediated mutual interaction between tumor cells and mesothelial cells contributes to peritoneal metastasis of gastric cancer. Int J Biol Sci 19(2):465\u2013483","journal-title":"Int J Biol Sci"},{"issue":"9","key":"2669_CR19","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1158\/1078-0432.CCR-23-3841","volume":"30","author":"M Wehrli","year":"2024","unstructured":"Wehrli M, Guinn S, Birocchi F, Kuo A, Sun Y, Larson RC, Almazan AJ, Scarf\u00f2 I, Bouffard AA, Bailey SR et al (2024) Mesothelin CAR T cells secreting anti-FAP\/anti-CD3 molecules efficiently target pancreatic adenocarcinoma and its stroma. Clin Cancer Res 30(9):1859\u20131877","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2669_CR20","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.3390\/ijms26052145","volume":"26","author":"T Nakatsura","year":"2025","unstructured":"Nakatsura T, Takenouchi K, Kataoka J, Ito Y, Kikuchi S, Kinoshita H, Ohnuki K, Suzuki T, Tsukamoto N (2025) Expression profiles of five common cancer membrane protein antigens collected for the development of cocktail CAR-T cell therapies applicable to most solid cancer patients. Int J Mol Sci 26(5):2145","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2669_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","volume":"20","author":"MJ Mitchell","year":"2021","unstructured":"Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R (2021) Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov 20(2):101\u2013124","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"2669_CR22","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/14789450.2018.1429924","volume":"15","author":"L Kuhlmann","year":"2018","unstructured":"Kuhlmann L, Cummins E, Samudio I, Kislinger T (2018) Cell-surface proteomics for the identification of novel therapeutic targets in cancer. Expert Rev Proteomics 15(3):259\u2013275","journal-title":"Expert Rev Proteomics"},{"issue":"1","key":"2669_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/1541-7786.MCR-19-0582","volume":"18","author":"P Khongorzul","year":"2020","unstructured":"Khongorzul P, Ling CJ, Khan FU, Ihsan AU, Zhang J (2020) Antibody-Drug conjugates: a comprehensive review. Mol Cancer Res 18(1):3\u201319","journal-title":"Mol Cancer Res"},{"issue":"5","key":"2669_CR24","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3390\/cells13050451","volume":"13","author":"A Maia","year":"2024","unstructured":"Maia A, Tarannum M, L\u00e9rias JR, Piccinelli S, Borrego LM, Maeurer M, Romee R, Castillo-Martin M (2024) Building a better defense: expanding and improving natural killer cells for adoptive cell therapy. Cells 13(5):451","journal-title":"Cells"},{"issue":"1","key":"2669_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-11105-8","volume":"15","author":"B Tu","year":"2025","unstructured":"Tu B, Wu J, Zhang W, Tang H, Dai T, Xie B (2025) A novel cancer-associated membrane signature predicts prognosis and therapeutic response for lung adenocarcinoma. Sci Rep 15(1):25482","journal-title":"Sci Rep"},{"issue":"11","key":"2669_CR26","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.1111\/cas.16285","volume":"115","author":"S Meng","year":"2024","unstructured":"Meng S, Hara T, Miura Y, Ishii H (2024) Fibroblast activation protein constitutes a novel target of chimeric antigen receptor T-cell therapy in solid tumors. Cancer Sci 115(11):3532\u20133542","journal-title":"Cancer Sci"},{"key":"2669_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1433679","volume":"15","author":"W Niu","year":"2024","unstructured":"Niu W, Wang B, Zhang Y, Wang C, Cao J, Li J, He Y, Lei P (2024) Efficacy and safety evaluation of cross-reactive Fibroblast activation protein scFv-based CAR-T cells. Front Immunol 15:1433679","journal-title":"Front Immunol"},{"issue":"1","key":"2669_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-021-00663-1","volume":"7","author":"Q Xu","year":"2021","unstructured":"Xu Q, Chen S, Hu Y, Huang W (2021) Single-cell RNA transcriptome reveals the intra-tumoral heterogeneity and regulators underlying tumor progression in metastatic pancreatic ductal adenocarcinoma. Cell Death Discov 7(1):331","journal-title":"Cell Death Discov"},{"issue":"9","key":"2669_CR29","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41422-019-0195-y","volume":"29","author":"J Peng","year":"2019","unstructured":"Peng J, Sun BF, Chen CY, Zhou JY, Chen YS, Chen H, Liu L, Huang D, Jiang J, Cui GS et al (2019) Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma. Cell Res 29(9):725\u2013738","journal-title":"Cell Res"},{"issue":"1","key":"2669_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40727-7","volume":"14","author":"S Zhang","year":"2023","unstructured":"Zhang S, Fang W, Zhou S, Zhu D, Chen R, Gao X, Li Z, Fu Y, Zhang Y, Yang F et al (2023) Single cell transcriptomic analyses implicate an immunosuppressive tumor microenvironment in pancreatic cancer liver metastasis. Nat Commun 14(1):5123","journal-title":"Nat Commun"},{"issue":"5","key":"2669_CR31","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1007\/s13402-025-01100-6","volume":"48","author":"J Wu","year":"2025","unstructured":"Wu J, Dai T, Li Z, Pan M, Zhang W, Chen H, Zheng G, Qiao L, Lian Q, Liu Y et al (2025) Integrating multi-modal transcriptomics identifies cellular subtypes with distinct roles in PDAC progression. Cell Oncol (Dordr) 48(5):1571\u201392","journal-title":"Cell Oncol (Dordr)"},{"issue":"9","key":"2669_CR32","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1016\/j.ccell.2025.06.020","volume":"43","author":"MM Chen","year":"2025","unstructured":"Chen MM, Gao Q, Ning H, Chen K, Gao Y, Yu M, Liu CQ, Zhou W, Pan J, Wei L et al (2025) Integrated single-cell and spatial transcriptomics uncover distinct cellular subtypes involved in neural invasion in pancreatic cancer. Cancer Cell 43(9):1656-1676.e1610","journal-title":"Cancer Cell"},{"issue":"1","key":"2669_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40314-w","volume":"14","author":"M Xue","year":"2023","unstructured":"Xue M, Zhu Y, Jiang Y, Han L, Shi M, Su R, Wang L, Xiong C, Wang C, Wang T et al (2023) Schwann cells regulate tumor cells and cancer-associated fibroblasts in the pancreatic ductal adenocarcinoma microenvironment. Nat Commun 14(1):4600","journal-title":"Nat Commun"},{"issue":"1","key":"2669_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04051-4","volume":"21","author":"K Chen","year":"2023","unstructured":"Chen K, Wang Q, Liu X, Tian X, Dong A, Yang Y (2023) Immune profiling and prognostic model of pancreatic cancer using quantitative pathology and single-cell RNA sequencing. J Transl Med 21(1):210","journal-title":"J Transl Med"},{"issue":"1","key":"2669_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-00776-9","volume":"12","author":"W Lin","year":"2020","unstructured":"Lin W, Noel P, Borazanci EH, Lee J, Amini A, Han IW, Heo JS, Jameson GS, Fraser C, Steinbach M et al (2020) Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions. Genome Med 12(1):80","journal-title":"Genome Med"},{"issue":"10064","key":"2669_CR36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0140-6736(16)32455-2","volume":"389","author":"AV Balar","year":"2017","unstructured":"Balar AV, Galsky MD, Rosenberg JE, Powles T, Petrylak DP, Bellmunt J, Loriot Y, Necchi A, Hoffman-Censits J, Perez-Gracia JL et al (2017) Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial. Lancet 389(10064):67\u201376","journal-title":"Lancet"},{"issue":"2","key":"2669_CR37","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao Y, Stuart T, Kowalski MH, Choudhary S, Hoffman P, Hartman A, Srivastava A, Molla G, Madad S, Fernandez-Granda C et al (2024) Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat Biotechnol 42(2):293\u2013304","journal-title":"Nat Biotechnol"},{"issue":"12","key":"2669_CR38","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, Baglaenko Y, Brenner M, Loh PR, Raychaudhuri S (2019) Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods 16(12):1289\u20131296","journal-title":"Nat Methods"},{"issue":"11","key":"2669_CR39","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/s41587-021-00935-2","volume":"39","author":"E Zhao","year":"2021","unstructured":"Zhao E, Stone MR, Ren X, Guenthoer J, Smythe KS, Pulliam T, Williams SR, Uytingco CR, Taylor SEB, Nghiem P et al (2021) Spatial transcriptomics at subspot resolution with BayesSpace. Nat Biotechnol 39(11):1375\u20131384","journal-title":"Nat Biotechnol"},{"issue":"D1","key":"2669_CR40","doi-asserted-by":"publisher","first-page":"D870","DOI":"10.1093\/nar\/gkac947","volume":"51","author":"C Hu","year":"2023","unstructured":"Hu C, Li T, Xu Y, Zhang X, Li F, Bai J, Chen J, Jiang W, Yang K, Ou Q et al (2023) CellMarker 2.0: an updated database of manually curated cell markers in human\/mouse and web tools based on scRNA-seq data. Nucleic Acids Res 51(D1):D870-d876","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"2669_CR41","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","volume":"9","author":"E Elyada","year":"2019","unstructured":"Elyada E, Bolisetty M, Laise P, Flynn WF, Courtois ET, Burkhart RA, Teinor JA, Belleau P, Biffi G, Lucito MS et al (2019) Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. Cancer Discov 9(8):1102\u20131123","journal-title":"Cancer Discov"},{"issue":"10","key":"2669_CR42","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu X, Mao Q, Tang Y, Wang L, Chawla R, Pliner HA, Trapnell C (2017) Reversed graph embedding resolves complex single-cell trajectories. Nat Methods 14(10):979\u2013982","journal-title":"Nat Methods"},{"issue":"1","key":"2669_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan C-H, Myung P, Plikus MV, Nie Q (2021) Inference and analysis of cell-cell communication using CellChat. Nat Commun 12(1):1088","journal-title":"Nat Commun"},{"issue":"5","key":"2669_CR44","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA (2015) Robust enumeration of cell subsets from tissue expression profiles. Nat Methods 12(5):453\u2013457","journal-title":"Nat Methods"},{"issue":"9","key":"2669_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107468","volume":"9","author":"P Geeleher","year":"2014","unstructured":"Geeleher P, Cox N, Huang RS (2014) pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels. PLoS ONE 9(9):e107468","journal-title":"PLoS ONE"},{"issue":"4","key":"2669_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2025.e42791","volume":"11","author":"Z Ding","year":"2025","unstructured":"Ding Z, Wu J, Ye Y, Zhong Y, Yan L, Wang P (2025) A novel signature predicts prognosis in pancreatic cancer based on tumor membrane-associated genes. Heliyon 11(4):e42791","journal-title":"Heliyon"},{"issue":"8051","key":"2669_CR47","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41586-024-07947-3","volume":"638","author":"D Zhang","year":"2025","unstructured":"Zhang D, Duque-Jimenez J, Facchinetti F, Brixi G, Rhee K, Feng WW, J\u00e4nne PA, Zhou X (2025) Transferrin receptor targeting chimeras for membrane protein degradation. Nature 638(8051):787\u2013795","journal-title":"Nature"},{"issue":"1","key":"2669_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02566-x","volume":"11","author":"H Masuda","year":"2025","unstructured":"Masuda H (2025) Cancer-associated fibroblasts in cancer drug resistance and cancer progression: a review. Cell Death Discov 11(1):341","journal-title":"Cell Death Discov"},{"issue":"8","key":"2669_CR49","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.7150\/ijbs.108618","volume":"21","author":"Y Wu","year":"2025","unstructured":"Wu Y, Li S, Yu H, Zhang S, Yan L, Guan X, Xu W, Wang Z, Lv A, Tian X et al (2025) Integrative single-cell and spatial transcriptomics analysis reveals ECM-remodeling cancer-associated fibroblast-derived POSTN as a key mediator in pancreatic ductal adenocarcinoma progression. Int J Biol Sci 21(8):3573\u20133596","journal-title":"Int J Biol Sci"},{"issue":"1","key":"2669_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06481-4","volume":"15","author":"X Cui","year":"2024","unstructured":"Cui X, Huo D, Wang Q, Wang Y, Liu X, Zhao K, You Y, Zhang J, Kang C (2024) RUNX1\/NPM1\/H3K4me3 complex contributes to extracellular matrix remodeling via enhancing FOSL2 transcriptional activation in glioblastoma. Cell Death Dis 15(1):98","journal-title":"Cell Death Dis"},{"issue":"7","key":"2669_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03938-8","volume":"12","author":"G Ma","year":"2021","unstructured":"Ma G, Li G, Fan W, Xu Y, Song S, Guo K, Liu Z (2021) Circ-0005105 activates COL11A1 by targeting miR-20a-3p to promote pancreatic ductal adenocarcinoma progression. Cell Death Dis 12(7):656","journal-title":"Cell Death Dis"},{"issue":"3","key":"2669_CR52","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/cas.16418","volume":"116","author":"Z Wang","year":"2025","unstructured":"Wang Z, Guo X, Li X, Wang J, Zhang N, Amin B, Xu G, Zhu B (2025) Cancer-associated fibroblast-derived MMP11 promotes tumor progression in pancreatic cancer. Cancer Sci 116(3):643\u2013655","journal-title":"Cancer Sci"},{"issue":"1","key":"2669_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-025-03867-y","volume":"25","author":"J Zou","year":"2025","unstructured":"Zou J, Zhang J, Li Y, Yuan B, Wang Y, Qi Y, Wang Q, Qin W, Yuan X, Xu B (2025) Stromal PLAU mediates tumor progression and informs a novel therapeutic target in triple-negative breast cancer. Cancer Cell Int 25(1):259","journal-title":"Cancer Cell Int"},{"issue":"1","key":"2669_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.111612","volume":"28","author":"L Liu","year":"2025","unstructured":"Liu L, Huang H, Cheng B, Xie H, Peng W, Cui H, Liang J, Cao M, Yang Y, Chen W et al (2025) Revealing the role of cancer-associated fibroblast senescence in prognosis and immune landscape in pancreatic cancer. iScience 28(1):111612","journal-title":"iScience"},{"key":"2669_CR55","doi-asserted-by":"crossref","unstructured":"Chen P, Yang J, Jin S, Li Y, Li D, Zhong C, Zhang Y, Xia Q, Fan X, Lin H (2025) TMEM158 promotes ICC metastasis via inducing lactic acid mediated reduction of actin skeleton stiffness of ICC cells. J Adv Res","DOI":"10.1016\/j.jare.2025.04.003"},{"issue":"6","key":"2669_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41397-024-00357-8","volume":"24","author":"X Zhu","year":"2024","unstructured":"Zhu X, Liu T, Yin X (2024) TMEM158, as plasma cfRNA marker, promotes proliferation and doxorubicin resistance in ovarian cancer. Pharmacogenomics J 24(6):34","journal-title":"Pharmacogenomics J"},{"issue":"3","key":"2669_CR57","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41417-024-00733-3","volume":"31","author":"J Li","year":"2024","unstructured":"Li J, Wang X, Chen L, Zhang J, Zhang Y, Ren X, Sun J, Fan X, Fan J, Li T et al (2024) Correction: TMEM158 promotes the proliferation and migration of glioma cells via STAT3 signaling in glioblastomas. Cancer Gene Ther 31(3):495\u2013496","journal-title":"Cancer Gene Ther"},{"issue":"2","key":"2669_CR58","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1002\/jcb.29433","volume":"121","author":"R Li","year":"2020","unstructured":"Li R, Weng L, Liu B, Zhu L, Zhang X, Tian G, Hu L, Li Q, Jiang S, Shang M (2020) TRIM59 predicts poor prognosis and promotes pancreatic cancer progression via the PI3K\/AKT\/mTOR-glycolysis signaling axis. J Cell Biochem 121(2):1986\u20131997","journal-title":"J Cell Biochem"},{"key":"2669_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1060957","volume":"13","author":"SMZ Hosen","year":"2022","unstructured":"Hosen SMZ, Uddin MN, Xu Z, Buckley BJ, Perera C, Pang TCY, Mekapogu AR, Moni MA, Notta F, Gallinger S et al (2022) Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: key role of the urokinase plasminogen activator (PLAU). Front Immunol 13:1060957","journal-title":"Front Immunol"},{"issue":"2","key":"2669_CR60","doi-asserted-by":"publisher","first-page":"e153842","DOI":"10.1172\/jci.insight.153842","volume":"7","author":"A Dasgupta","year":"2022","unstructured":"Dasgupta A, Arneson-Wissink PC, Schmitt RE, Cho DS, Ducharme AM, Hogenson TL, Krueger EW, Bamlet WR, Zhang L, Razidlo GL et al (2022) Anticachectic regulator analysis reveals Perp-dependent antitumorigenic properties of 3-methyladenine in pancreatic cancer. JCI Insight 7(2):e153842","journal-title":"JCI Insight"},{"issue":"1","key":"2669_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-30972-7","volume":"13","author":"H Zheng","year":"2023","unstructured":"Zheng H, Li Y, Zhao Y, Jiang A (2023) Single-cell and bulk RNA sequencing identifies T cell marker genes score to predict the prognosis of pancreatic ductal adenocarcinoma. Sci Rep 13(1):3684","journal-title":"Sci Rep"},{"issue":"1","key":"2669_CR62","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-01830-x","volume":"16","author":"Y Fan","year":"2025","unstructured":"Fan Y, Wu L, Qiu X, Shi H, Wu L, Lin J, Lin J, Teng T (2025) Single-cell RNA-seq analysis reveals microenvironmental infiltration of myeloid cells and pancreatic prognostic markers in PDAC. Discover Oncol 16(1):81","journal-title":"Discover Oncol"},{"issue":"1","key":"2669_CR63","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-025-01801-0","volume":"25","author":"W Wang","year":"2025","unstructured":"Wang W, Li H, Gong J, Liu Y (2025) Identification of a fibroblast-derived gene signature reveals prognostic and therapeutic insights in pancreatic cancer. Clin Exp Med 25(1):253","journal-title":"Clin Exp Med"},{"issue":"7","key":"2669_CR64","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1158\/2159-8290.CD-23-0428","volume":"14","author":"JI Belle","year":"2024","unstructured":"Belle JI, Sen D, Baer JM, Liu X, Lander VE, Ye J, Sells BE, Knolhoff BL, Faiz A, Kang LI et al (2024) Senescence defines a distinct subset of myofibroblasts that orchestrates immunosuppression in pancreatic cancer. Cancer Discov 14(7):1324\u20131355","journal-title":"Cancer Discov"},{"issue":"1","key":"2669_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166852","volume":"1870","author":"F Ge","year":"2024","unstructured":"Ge F, Zeng C, Wang J, Liu X, Zheng C, Zhang H, Yang L, Yang B, Zhu H, He Q (2024) Cancer-associated fibroblasts drive early pancreatic cancer cell invasion via the SOX4\/MMP11 signalling axis. Biochim Biophys Acta Mol Basis Dis 1870(1):166852","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"4","key":"2669_CR66","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.annonc.2020.01.013","volume":"31","author":"GR Oxnard","year":"2020","unstructured":"Oxnard GR, Yang JC, Yu H, Kim SW, Saka H, Horn L, Goto K, Ohe Y, Mann H, Thress KS et al (2020) TATTON: a multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer. Ann Oncol 31(4):507\u2013516","journal-title":"Ann Oncol"},{"issue":"7","key":"2669_CR67","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S1470-2045(19)30277-3","volume":"20","author":"J Fangusaro","year":"2019","unstructured":"Fangusaro J, Onar-Thomas A, Young Poussaint T, Wu S, Ligon AH, Lindeman N, Banerjee A, Packer RJ, Kilburn LB, Goldman S et al (2019) Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial. Lancet Oncol 20(7):1011\u20131022","journal-title":"Lancet Oncol"},{"issue":"7","key":"2669_CR68","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.3390\/ijms19072077","volume":"19","author":"S W\u00e4chter","year":"2018","unstructured":"W\u00e4chter S, Wunderlich A, Greene BH, Roth S, Elxnat M, Fellinger SA, Verburg FA,","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-026-02669-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-026-02669-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-026-02669-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:02:13Z","timestamp":1775520133000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-026-02669-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2669"],"URL":"https:\/\/doi.org\/10.1007\/s00109-026-02669-7","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}